Investing.com - Novo Nordisk (NYSE:NVO) ADR reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novo Nordisk ADR announced earnings per share of kr5.45 on revenue of kr33.8B. Analysts polled by Investing.com anticipated EPS of kr0.8101 on revenue of kr5.19B.
Novo Nordisk ADR shares are up 8% from the beginning of the year, still down 2.28% from its 52 week high of kr75.86 set on February 12. They are under-performing the S&P 500 which is up 10.86% from the start of the year.
Novo Nordisk ADR shares gained 2.17% in pre-market trade following the report.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by J&J on April 20, who reported EPS of kr2.59 on revenue of kr22.32B, compared to forecasts EPS of kr2.34 on revenue of kr21.98B.
Pfizer had beat expectations on Tuesday with first quarter EPS of kr0.93 on revenue of kr14.58B, compared to forecast for EPS of kr0.7773 on revenue of kr13.67B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar